Prokineticin

Overview

The prokineticins are a family of small cysteine-rich secreted proteins comprising prokineticin 1 (PK1, also known as endocrine gland-derived VEGF or EG-VEGF) and prokineticin 2 (PK2, the mammalian homolog of frog Bv8). Their name derives from their initial identification as promoters of gastrointestinal smooth muscle contraction — "prokinetic" agents. The family was characterized in the early 2000s through convergent research lines studying gut motility, angiogenesis, and pain.

Prokineticins are structurally defined by a conserved AVIT motif (Ala-Val-Ile-Thr) at the N-terminus and ten conserved cysteine residues forming five disulfide bonds that create a compact, stable tertiary structure known as the colipase fold. This structure is highly conserved from invertebrates (mamba snake venom contains the homolog MIT1) to mammals, suggesting ancient biological importance.

The prokineticin system has attracted research interest across an unusually broad range of biological processes. PK2 is a clock-controlled gene regulated by CLOCK/BMAL1 transcription factors in the suprachiasmatic nucleus, making it a direct circadian output signal. PK1 promotes tissue-specific angiogenesis in endocrine organs. Both prokineticins are potent pain sensitizers that hyperactivate nociceptors. Additionally, PK2 mutations cause Kallmann syndrome (hypogonadotropic hypogonadism with anosmia), revealing a critical role in GnRH neuron migration and olfactory bulb development.

Structure

Prokineticin 1 (PK1/EG-VEGF): 86 amino acids Prokineticin 2 (PK2/Bv8): 81 amino acids (with splice variants)

• Genes: PROK1 (chromosome 1p13.3), PROK2 (chromosome 3p13)
• Receptors: PKR1 (prokineticin receptor 1), PKR2 (prokineticin receptor 2)

Structural features:

• AVIT N-terminal motif — Ala-Val-Ile-Thr is absolutely conserved and essential for receptor binding; modifications abolish activity
• 10 conserved cysteines — form 5 disulfide bonds creating the colipase fold (also found in MIT1 snake toxin and Bv8 frog skin protein)
• Compact globular structure — extremely protease-resistant due to disulfide cross-linking
• PK1 and PK2 share ~45% sequence identity and bind both receptors, though with different relative affinities

Mechanism of Action

Receptor Signaling

Prokineticins signal through two GPCRs:

PKR1:

• Widely expressed: GI tract, blood vessels, peripheral neurons, immune cells, heart, adipose tissue
• Couples to Gq (phospholipase C/calcium), Gs (cAMP), and Gi pathways depending on cell type
• Mediates peripheral pain sensitization, gut motility, and angiogenesis

PKR2:

• Predominantly CNS: suprachiasmatic nucleus, olfactory bulb, hypothalamus, thalamus
• Also expressed in testis and some peripheral tissues
• Mediates circadian output, olfactory bulb development, GnRH neuron migration
• PKR2 mutations cause Kallmann syndrome

Pain Sensitization

Prokineticins are among the most potent known nociceptor sensitizers:

• PK2/Bv8 activates PKR1 on primary sensory neurons (DRG neurons)
• Reduces nociceptor threshold and increases responsiveness to thermal and mechanical stimuli
• Potentiates TRPV1 channel activity — synergizes with capsaicin signaling
• Released by infiltrating immune cells (macrophages, neutrophils) in inflamed tissue
• Creates a link between inflammation and pain sensitization
• PKR1 antagonists produce analgesia in inflammatory and neuropathic pain models

Circadian Rhythm Regulation

• PK2 is a direct transcriptional target of the CLOCK/BMAL1 circadian transcription factors
• Expression in the suprachiasmatic nucleus (SCN) peaks during the light phase
• PK2 acts as a circadian output signal, transmitting clock information from the SCN to downstream brain regions via PKR2
• PK2 knockout mice show disrupted circadian rhythms in locomotor activity, body temperature, and sleep-wake cycles
• Connects the molecular clock to behavioral and physiological rhythms

Angiogenesis

• PK1 (EG-VEGF) promotes angiogenesis specifically in endocrine gland vasculature (ovary, testis, adrenal, placenta)
• Unlike VEGF, which broadly promotes angiogenesis, PK1 shows tissue selectivity
• Important for corpus luteum vascularization and placental development
• Overexpression associated with some endocrine tumors

Development: GnRH Neuron Migration

• PK2/PKR2 signaling is essential for GnRH neuron migration from the olfactory placode to the hypothalamus during embryonic development
• Loss-of-function mutations in PROK2 or PROKR2 cause Kallmann syndrome: failure of GnRH neurons to reach the hypothalamus + olfactory bulb dysgenesis
• This developmental role connects prokineticin biology to GnRH and reproductive endocrinology

Research Summary

Pharmacokinetics

• Half-life: Not precisely determined for endogenous prokineticins; the disulfide-stabilized structure confers significant protease resistance
• Expression: PK1: ovary, testis, adrenal, placenta, GI tract; PK2: SCN, olfactory bulb, hypothalamus, bone marrow, inflammatory cells
• Regulation: PK2 expression is circadian-controlled (CLOCK/BMAL1); PK1 is upregulated by hypoxia (HIF-1alpha)
• Circulating levels: Low; prokineticins function primarily as paracrine/autocrine factors

Common Discussion Topics

1. Multi-system peptide — Prokineticins are remarkable for the breadth of their biological roles: pain, circadian rhythms, angiogenesis, reproduction, development, and immunity. This diversity reflects widespread receptor expression and context-dependent signaling.

2. Pain therapeutic target — PKR1 antagonists represent a novel non-opioid analgesic approach, targeting the inflammatory pain sensitization pathway rather than opioid receptors. This positions prokineticins in the broader landscape of pain research alongside CGRP and substance P.

3. Circadian output signal — PK2 is one of the clearest examples of a peptide that directly transmits circadian clock information to behavioral output, bridging molecular circadian rhythm biology and whole-organism physiology.

4. Kallmann syndrome genetics — PROK2/PROKR2 mutations account for approximately 5-10% of Kallmann syndrome cases, establishing prokineticins as critical for human reproductive development.

5. Evolutionary origin — The colipase/AVIT fold is found in snake venom (MIT1) and frog skin secretions (Bv8), where these peptides serve defensive/offensive functions. Their co-option into mammalian physiology illustrates how ancient protein folds can be repurposed across evolution.

Related Compounds

• CGRP — nociceptive neuropeptide involved in migraine and pain sensitization
• Substance P — pain-transmitting neuropeptide with complementary nociceptive roles
• VIP — vasoactive intestinal peptide with GI motility and circadian functions
• Orexin-A — wakefulness peptide with circadian and arousal functions
• Adrenomedullin — vascular peptide with angiogenic properties